Stocks and securities in focus
| Security | Change (%) | 1w ▼ | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novavax Inc. | 97.310% | 80.837% | 108.011% | 0.917% | 84.927% | -93.750% | 26.254% |
| Inogen Inc. | 2.610% | 22.901% | 12.587% | -21.078% | 51.887% | -85.364% | - |
| Novocure Ltd | -1.990% | 11.707% | 12.652% | -76.475% | 7.285% | -89.787% | - |
| Fibrogen Inc. | -9.390% | 2.560% | -18.470% | -93.324% | 25.756% | -93.232% | - |
| Fate Therapeutics Inc. | 9.850% | 0.317% | -38.485% | -21.923% | 6.665% | -93.920% | - |
| Biolife Solutions Inc | -3.510% | -0.602% | 3.774% | -2.941% | 10.738% | -36.392% | 14.329% |
| Ironwood Pharmaceuticals | - | -1.316% | 1.351% | -19.786% | -26.471% | -18.033% | - |
| Cardiff Oncology Inc. | -1.670% | -1.991% | -41.392% | 105.392% | 143.161% | -58.974% | -8.571% |
| Chromadex Corp | -1.120% | -2.286% | -6.044% | 155.224% | 155.224% | -44.839% | - |
| Viking Therapeutics Inc | -7.140% | -4.337% | 2.549% | 230.818% | 291.078% | 1342.616% | - |
| Cytokinetics Inc. | -0.840% | -4.918% | -16.547% | 66.667% | -24.183% | 198.969% | - |
| Ocular Therapeutix Inc. | -5.620% | -8.170% | -28.513% | -10.923% | 25.357% | -57.920% | 62.396% |
| Akebia Therapeutics Inc. | -5.620% | -12.373% | -22.668% | 19.807% | -4.522% | -53.375% | - |
| Sage Therapeutics Inc. | 0.610% | -14.738% | -27.778% | -76.979% | -44.750% | -82.131% | - |
| Cytomx Therapeutics Inc | -15.850% | -55.310% | -5.969% | 10.890% | 32.020% | -72.574% | - |
| MacroGenics Inc. | -77.710% | -78.352% | -81.918% | -53.424% | -65.844% | -88.752% | - |
| Revance Therapeutics Inc. | -22.280% | - | - | - | - | - | - |
| Apellis Pharmaceuticals | -1.890% | - | - | - | - | - | - |